Clinical Trial Update: Pure Red Cell Aplasia in Patients With Chronic Kidney Disease and in Use of Epoetin Alfa [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining pure red cell aplasia in patients with chronic kidney disease treated with epoetin alfa. Sponsor: The Immunobiological T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Pure Red Cell Aplasia

Drugs mentioned

• EPOETIN ALFA (EPOETIN ALFA)

Snippet

Sponsor: The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) | Conditions: Red-Cell Aplasia, Pure, Renal Insufficiency, Chronic | Phase 4 | Status: UNKNOWN